But even if you know how to use Microsoft Word, you might not be aware that you can even draw and sketch in the application. Whether you’d like to call attention to a certain part of your ...

The SDR is an international reserve asset created by the IMF to supplement the official reserves of its member countries. The SDR is not a currency. It is a potential claim on the freely usable ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

The University of North Carolina-affiliated health system announced a plan this month to launch UNC Health Pharmacy Solutions, a "transparent" PBM for employers seeking an alternative to CVS ...

Opinions expressed by Forbes Contributors are their own. I write about business model strategy and execution across healthcare. On the heels of the FTC’s investigation into pharmacy benefit ...

Follow our simple instructions to draw a cartoon T. rex and read on to find out how professional artists bring dinosaurs to life with their pictures. Tyrannosaurus rex is probably the most famous ...

Psyence Biomedical Ltd (NASDAQ:PBM) shares are trading lower by 28.6% to $0.25 during Wednesday’s session. The company earlier announced it entered into an exclusive licensing agreement with ...

For years, PBMs have described themselves as partners of health care plans and self-insured employers in the management of their respective prescription drug benefits. Likewise, pharmacy directors ...

PBM stock is up 162.6% as of Thursday morning. The stock was down 83.3% year-to-date when markets closed yesterday. Investors will want to keep reading for more of the most recent stock market ...

Five Card Draw is the the ultimate poker showdown. Draw your hand, outbet your opponents and seize victory with the best 5-card hand or a compelling bluff. The objective of Five Card Draw is to ...

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder ...